Description: AltPep develops early disease-modifying treatments and detection tools for amyloid diseases.Our lead programs aim to identify Alzheimer’s disease and Parkinson’s disease long before symptoms occur and then neutralize toxic soluble oligomers associated with these diseases.
diagnostic (802) biotech (646) detection (292) research associate (6) research facility (4) seattle startup (1) seattle biotech (1)
AltPep develops early disease-modifying treatments and detection tools for amyloid diseases.
Our lead programs aim to identify Alzheimer’s disease and Parkinson’s disease long before symptoms occur and then neutralize toxic soluble oligomers associated with these diseases.
The AltPep platform, the foundation of our diagnostic and therapeutic programs, is based on a library of custom designed synthetic peptides. This growing library is being used to target one of the earliest molecular triggers of amyloid diseases.